Nasdaq - Delayed Quote USD

Eventide Healthcare & Life Sciences N (ETNHX)

30.72
+1.03
+(3.47%)
At close: 8:05:39 AM EDT

Top 9 Holdings (30.15% of Total Assets)

SymbolCompany% Assets
Verona Pharma plc 4.41%
Scholar Rock Holding Corporation 3.97%
Mirum Pharmaceuticals, Inc. 3.73%
Insmed Incorporated 3.60%
Guardant Health, Inc. 3.43%
Blueprint Medicines Corporation 2.93%
Collegium Pharmaceutical, Inc. 2.85%
Celldex Therapeutics, Inc. 2.65%
Aura Biosciences, Inc. 2.59%

Sector Weightings

SectorETNHX
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Cash 5.90%
Stocks 90.51%
Bonds 0.00%
Others 0.55%
Preferred 3.01%
Convertible 0.03%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average ETNHX Category Average
Price/Earnings 0 24.55
Price/Book 0.24 5.28
Price/Sales 0.17 2.06
Price/Cashflow 0 17.54
Median Market Cap 3,273.14 34,862.81
3 Year Earnings Growth 0 32.48

Bond Holdings

Average ETNHX Category Average
Maturity -- --
Duration 1.05 --
Credit Quality -- --

Performance & Risk

YTD Return -8.53%
5y Average Return -2.24%
Rank in Category (ytd) 75
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.63
Morningstar Risk Rating

Fund Overview

Category Health
Fund Family Eventide Funds
Net Assets 1.09B
YTD Return -4.04%
Yield 0.00%
Morningstar Rating
Inception Date Dec 27, 2012

Fund Summary

Under normal market conditions, the fund invests at least 80% of its net assets (plus borrowings for investment purposes) in equity and equity-related securities of companies in the healthcare and life sciences sectors, including common stock, options, preferred stock and convertible debt. It may invest without limitation in securities of companies domiciled outside the United States either directly or through American Depositary Receipts ("ADRs"). The fund may invest in securities of companies of any market capitalization.

Related Tickers